• Most Popular
  • Most Shared

Sanofi sues Teva over Eloxatin patent

Wed Jun 20, 2007 4:01pm EDT

Stocks

   

NEW YORK, June 20 (Reuters) - Sanofi-Aventis (SASY.PA) has sued Teva Industries Ltd. (TEVA.TA)(TEVA.O) over Teva's plans to sell a generic version of the French drugmaker's cancer treatment Eloxatin, according to court documents filed this week.

The lawsuit, filed on Monday in federal court in New Jersey, comes on the heels of a similar suit filed there last week by Sanofi against Sandoz, a unit of Novartis (NOVN.VX).

Eloxatin had nearly 1.7 billion euros in sales in 2006 for Sanofi, the world's third largest drugmaker.

In an amended complaint filed on Wednesday, Sanofi alleged that Teva's plan to make and sell a generic version of the drug infringed a patent for which it was an exclusive licensee.

Teva filed a new drug application with the FDA for a generic product, oxaliplatin injection, according to the complaint. Oxaliplatin is the active ingredient in Eloxatin.

Sanofi is seeking an order blocking Teva from making or selling the generic product in the United States.

Teva and Sanofi could not be reached immediately for comment.

(Reporting by Paritosh Bansal)

((Editing by Tim Dobbyn; Tel: 212-393-9461; paritosh.bansal@reuters.com)) Keywords: SANOFI TEVA/SUIT

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nN20294930


More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    PICTURES
    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    Oddly Enough
    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

    Global Markets